Three New Treatments Bring Good News for People With Crohn's

Infliximab has been found to be especially effective in treating the inflammation associated with Crohn's disease, but also effectively treats fistulas. Fistulizing Crohn's disease involves the abnormally connected intestines and organs. Infliximab was found to reduce the number of those fistulas.

Infliximab is not safe for everyone. The medication may cause complications in the event of pregnancy, heart problems, nervous system disorders, and a history of tuberculosis. Infliximab is made from the cells of mice so it is not generally recommended for anyone who is allergic to rodents. There are various side effects associated with taking infliximab and they include hives, breathing difficulties, low blood pressure, chest pain, nausea, headaches, skin rashes, and itchy skin.